LTR Pharma (ASX:LTP) Deferred Tax: A$0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:LTP LTR Pharma Ltd ASX:LTP
6 GF Score
Price A$0.54
! 2 Warning Signs
View Full Analysis

What is LTR Pharma Deferred Tax?

LTR Pharma ASX:LTP +4.90% 6 Deferred Tax is A$0.00 Mil as of Jun. 2026. GuruFocus rates ASX:LTP with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

LTR Pharma's change in deferred tax for the six months ended in Jun. 2026 was A$0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.00 Mil.

LTR Pharma Deferred Tax Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Deferred Tax Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Deferred Tax
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Deferred Tax Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:LTP
6GF Score
LTR Pharma Ltd ASX:LTP
Deferred Tax is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Deferred Tax →
What does a Deferred Tax of A$0.00 Mil mean?
LTR Pharma (ASX:LTP) has a Deferred Tax of A$0.00 Mil as of Jun. 2026. Change in Defered Tax is amount of deferred tax assets or liabilities due to temporary differences in financial and tax accounting. View historical data for LTR Pharma.
Is LTR Pharma's Deferred Tax too high?
LTR Pharma's current Deferred Tax is A$0.00 Mil. Overall, LTR Pharma has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Deferred Tax compare to VRTX and REGN?
LTR Pharma's Deferred Tax of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Deferred Tax for a Biotechnology company?
A good Deferred Tax depends on the Biotechnology industry context. However, Deferred Tax should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Deferred Tax mean?
A high Deferred Tax can signal that a stock is expensive relative to its fundamentals. Change in Defered Tax is amount of deferred tax assets or liabilities due to temporary differences in financial and tax accounting. View historical data for LTR Pharma. LTR Pharma's current Deferred Tax is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Deferred Tax of A$0.00 Mil. The current Deferred Tax is A$0.00 Mil. LTR Pharma's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Deferred Tax calculated?
Deferred Tax is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Deferred Tax is A$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
6GF Score

Get the complete analysis for ASX:LTP

Deferred Tax is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.54
Price